Effect of immunization with Ii-key modified HER2 (776-790) peptide vaccine (AE37) on immunologic responses in prostate cancer patients.

Sonia A. Perez,Eleftheria A. Anastasopoulou,Efi Pappou,Panagiotis Tzonis,Stratos Bisias,A. Thanos,Eric von Hofe,Michael Papamichail,Constantin N. Baxevanis

Effect of immunization with Ii-key modified HER2 (776-790) peptide vaccine (AE37) on immunologic responses in prostate cancer patients.

2017

Sonia A. Perez
Eleftheria A. Anastasopoulou
Efi Pappou
Panagiotis Tzonis
Stratos Bisias
A. Thanos
Eric von Hofe
Michael Papamichail
Constantin N. Baxevanis

e16037 Background: We have shown that the AE37 vaccine (Ii-Key modified HER2(776-790) peptide) is safe and induces HER2/neu–specific cellular immune responses in patients with prostate cancer (Pere...

Keywords:

Immunology
Pathology
Peptide vaccine
AE37 vaccine
Immune system
Prostate cancer
Peptide
Medicine
in patient

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations